Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00574457 · ClinicalTrials.gov registry record · Phase 4

Improving Cardiovascular Risk Prediction Using Hand Held Carotid Ultrasonography Study

A Phase 4 study of Stroke and Atherosclerosis, sponsored by University of Wisconsin, Madison.

Completed
Registry status
Phase 4
Development phase
355
Enrollment target
5
Study locations

NCT00574457: Completed Phase 4 study of Stroke and Atherosclerosis, sponsored by University of Wisconsin, Madison.

NCT00574457 is a Phase 4 study of Stroke and Atherosclerosis that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 355 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00574457, a Phase 4 study of Stroke and Atherosclerosis, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
Phase 4
Development phase
355 participants
Enrollment target
5
Study locations

Study Summary

1\) Research questions: 1a. Can non-sonographer health care professionals in a community medical office practice setting be trained to detect and evaluate subclinical atherosclerosis? 1b. Can carotid ultrasound performed in community office practices improve physician use of evidence-based, risk-reducing interventions and patient motivation to adhere to therapeutic recommendations?

Conditions Studied

Interventions

  • OTHER Carotid Ultrasound

Study Locations (5)

Wisconsin

  • Internal Medicine and Pediatrics, S.C. - Fort Atkinson
  • Mercy Clinic East - Janesville
  • ProHealth Care Medical Centers - Oconomowoc
  • Turke Family Medicine S.C. - Watertown
  • Moreland Family Medicine Associates, S.C. - Waukesha

Trial Details

FieldValue
Enrollment Target 355 participants
Start Date 2007-09
Est. Completion 2009-09
Phase Phase 4
University of Wisconsin, Madison

1,039 total trials

What the finished NCT00574457 record still lists

NCT00574457 is an interventional study that assigns participants to a tested intervention. The registered 355 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Carotid Ultrasound is the first listed.

NCT00574457 lists 5 locations in 1 state (Wisconsin).

Frequently Asked Questions

What is clinical trial NCT00574457 about?

NCT00574457 is a clinical study titled "Improving Cardiovascular Risk Prediction Using Hand Held Carotid Ultrasonography Study". 1\) Research questions: 1a. Can non-sonographer health care professionals in a community medical office practice setting be trained to detect and evaluate subclinical atherosclerosis? 1b. Can carotid ultrasound performed in community office practices improve physician use of evidence-based, risk-r...

What is the current status of trial NCT00574457?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 355 participants. The study started on 2007-09. Estimated completion is 2009-09.

What conditions does trial NCT00574457 study?

This clinical trial studies the following conditions: Stroke, Atherosclerosis.

What interventions are being tested in trial NCT00574457?

The interventions under investigation include: Carotid Ultrasound (OTHER).

Who is sponsoring clinical trial NCT00574457?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00574457 being conducted?

This trial has 5 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00574457's enrollment target sits among peer trials

355 70th of 454 higher than 385 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07133308 · 355 participants · Phase 3

    Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

  • NCT07193511 · 355 participants · Phase 1

    BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

  • NCT06077838 · 356 participants · NA

    RELAXaHEAD for Headache Patients (Phase III)

  • NCT06293469 · 356 participants · NA

    Accelerated Flap Coverage in Severe Lower Extremity Trauma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00574457, the US trial registry maintained by the National Library of Medicine. NCT00574457 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.